BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 109 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,858,000 | +42.8% | 293,567 | -0.5% | 0.00% | 0.0% |
| Q3 2016 | $1,301,000 | +64.7% | 295,020 | +6.1% | 0.00% | +100.0% |
| Q2 2016 | $790,000 | +6.8% | 278,020 | +6.3% | 0.00% | 0.0% |
| Q1 2016 | $740,000 | -72.2% | 261,537 | +1.5% | 0.00% | -66.7% |
| Q4 2015 | $2,659,000 | -9.5% | 257,682 | +0.0% | 0.00% | -25.0% |
| Q3 2015 | $2,938,000 | -29.3% | 257,680 | -7.4% | 0.00% | -20.0% |
| Q2 2015 | $4,156,000 | +102.6% | 278,397 | +22.6% | 0.01% | +66.7% |
| Q1 2015 | $2,051,000 | -24.8% | 227,135 | +1.2% | 0.00% | -25.0% |
| Q4 2014 | $2,728,000 | +23.1% | 224,364 | -1.0% | 0.00% | +33.3% |
| Q3 2014 | $2,216,000 | -22.6% | 226,575 | +0.9% | 0.00% | -25.0% |
| Q2 2014 | $2,863,000 | – | 224,551 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |